Your Article Summary
See Latest ArticlesSuccessful Control of Intractable Hypoglycemia Using Rapamycin in an 86-year old man with a Pancreatic Insulin-Secreting Islet Cell Tumor and Metastases
Journal of Clinical Endocrinology and Metabolism, 07/02/09
Bourcier ME et al. - Rapamycin may provide a useful means of abrogating tumor growth and controlling hypoglycemia in malignant insulinomas by reducing the malignant beta cell growth and proliferation as well as inhibiting insulin production.
Related Articles
How Punctual Ablation of Regulatory T Cells Unleashes an Autoimmune Lesion within the Pancreatic Islets
Immunity, 10/27/09
Relevance Score: 81%
Transgenic Expression of Hsc70 in Pancreatic Islets Enhances Autoimmune Diabetes in Response to [beta] Cell Damage
Journal of Immunology, 10/27/09
Relevance Score: 81%
Is Antigen Specificity of Autoreactive T Cells the Key to Islet Entry
Immunity, 10/16/09
Relevance Score: 81%
Homozygous P86S Mutation of the Human Glucagon Receptor Is Associated With Hyperglucagonemia, [alpha] Cell Hyperplasia, and Islet Cell Tumor
Pancreas, 10/26/09
Relevance Score: 80%
PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression
Oncogene, 10/01/09
Relevance Score: 80%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/18/09
Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
International Journal of Women's Health, 12/18/09
Zigzagged Augmentation Index in Diabetes
Clinical and Experimental Hypertension, 12/18/09